The company may from time to time, in one or more offerings at prices and on terms that it will determine at the time of each offering, sell common stock, warrants, or a combination of these securities, or units, up to a total offering price of $200M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RENB:
- Renovaro BioSciences presents insights on Oxford Nanopore sequencing
- Renovaro BioSciences announces strategic restructuring, leadership transition
- Renovaro Biosciences Appoints New CEO and Board Members
- Renovaro BioSciences, PersonalAIze announce strategic partnership
- PersonalAIze conducted evaluation on Renovaro’s RenovaroCube
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
